Intranasal transmission of hepatitis C virus: virological and clinical evidence
- PMID: 18764772
- PMCID: PMC6545569
- DOI: 10.1086/591699
Intranasal transmission of hepatitis C virus: virological and clinical evidence
Abstract
Intranasal transmission of hepatitis C virus (HCV) via contaminated drug-sniffing implements is a potential but unconfirmed source of viral infection. We demonstrate the virological plausibility of intranasal transmission by confirming that blood and HCV RNA are present in the nasal secretions and drug-sniffing implements of HCV-infected intranasal drug users recruited from a community health clinic in New York City.
Conflict of interest statement
Figures
References
-
- Hollinger FB. Factors contributing to the evolution and outcome of cirrhosis in hepatitis C. Clin Liver Dis 1999; 3:741–55 - PubMed
-
- Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9:84–100. - PubMed
-
- Tortu S, Neaigus A, McMahon JM, Hagen D. Hepatitis C among non-injecting drug users: a report. Subst Use Misuse 2001; 36:523–34. - PubMed
-
- Conry-Cantilena C, van Raden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691–6. - PubMed
